作者
Douglas N Fish, Andrew T Chow
发表日期
1997/2
来源
Clinical pharmacokinetics
卷号
32
页码范围
101-119
出版商
Springer International Publishing
简介
Levofloxacin is a fluoroquinolone antibiotic and is the optical S-(−) isomer of the racemic drug substance ofloxacin. It has a broad spectrum of in vitro activity against Gram-positive and Gram-negative bacteria, as well as certain other pathogens such as Mycoplasma, Chlamydia, Legionella and Mycobacteria spp. Levofloxacin is significantly more active against bacterial pathogens than R- (+) - ofloxacin. Levofloxacin hemihydrate, the commercially formulated product, is 97.6% levofloxacin by weight.
Levofloxacin pharmacokinetics are described by a linear 2-compartment open model with first-order elimination. Plasma concentrations in healthy volunteers reach a mean peak drug plasma concentration (Cmax) of approximately 2.8 and 5.2 mg/L within 1 to 2 hours after oral administration of levofloxacin 250 and 500mg tablets, respectively. The bioavailability of oral levofloxacin approaches 100% and …
引用总数
19971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242121923322924183334192020161923152418292217242929283113
学术搜索中的文章